Ooma's Q2 FY27 Revenue Jumps 25% on Acquisitions, But Underlying Organic Growth Still Needs Scrutiny

What happened

Ooma reported fiscal second quarter 2027 revenue of $83.2 million, up 25% year-over-year, with subscription and services revenue rising to $75.6 million from $61.1 million, now representing 91% of total revenue. The surge likely reflects the contributions from the FluentStream and Phone.com acquisitions completed in December 2025, given that organic growth was only around 4% in the prior fiscal quarter. The release emphasizes top-line expansion but omits details on profitability, margins, or subscriber trends, which are critical given the company's history of thin GAAP earnings and integration challenges. This report comes after management guided to significant EBITDA accretion from the deals, but the market will need evidence that the acquisitions are not masking a continuing slowdown in the core business. Overall, the revenue beat is positive on its face, but the quality of that growth remains unproven until we see margin and churn data.

Implication

The 25% revenue jump is likely to be well received by the market, but it does little to resolve the core questions around organic growth sustainability and integration risk. Investors should treat this quarterly release as a partial validation of the acquisition strategy, while awaiting more granular disclosures on organic revenue growth, adjusted EBITDA margins, and customer retention metrics. If subsequent quarters show that organic growth remains at low single digits and margins fail to expand as promised, the stock's valuation will look increasingly stretched. Conversely, if the acquired businesses are performing above expectations and driving reacceleration, the bullish scenario becomes more credible. Until then, the wait-and-see stance remains appropriate, and we would not chase the shares higher based solely on this headline number.

Thesis delta

The master thesis remains largely unchanged: the stock is rated WAIT with a base implied value around $13, but this revenue report does not materially alter the risk-reward. The strong top-line growth from acquisitions supports the bull case but does not yet confirm the necessary EBITDA accretion or organic stabilization. We maintain our neutral stance and would look for evidence of organic growth reacceleration and improved profitability in the coming quarters before upgrading the stock.